Airsea pharmaceutical Co.

Company Description

In the most revolutionizing industry Airsea pharmaceutical Co. LLC has reached a milestone owing to the top notch production facility with technologically advanced equipment to manufacture first in class Oseltamivir, committing reliability, durability and optimum functioning. Since our inception, back in 2003 we have designed products to provide electrical solution having no match because we only source raw material that caters to durability, safety and meets international standards. Our export operations invaded international market as well, now holding Australia,Brazil,Canada,France,United Kingdom export market share with gross export ratio value of Above US$100 Million. Products we count on include Oseltamivir,Tilmicosin, Gentamycin sulphate, Fluoxetine HCL, Dopamine HCL, Flunixin Meglumine, Paroxetine,Linezolide, helping us generate overall annual revenue across Approx 2 Million US Dollar. Electronic products in the market never go out of demand and to successfully meet that, our production potential is always on point, thanks to our manufacturing facility with Third Party, situated in taizhou, Jiangsu, China.As a leading Manufacturer and Exporter, we hold export history of 17 Years , covering a milestone from where we began first with initial business capital of US$1 Million - US$2.5 Million.